Skip to content
10-Q

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-17-000030

← back to feed
Filed
May 30, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · May 2, 2017 81.5M sh
Stockholders Equity Q3 2017 · Mar 31, 2017 −$82.06K
Stockholders Equity Q3 2017 · Jun 30, 2016 −$11.96K
Current Liabilities Q3 2017 · Mar 31, 2017 $91.02K
Current Liabilities Q3 2017 · Jun 30, 2016 $75.92K
Current Assets Q3 2017 · Mar 31, 2017 $5.96K
Current Assets Q3 2017 · Jun 30, 2016 $53.47K
Total Assets Q3 2017 · Mar 31, 2017 $8.96K
Total Assets Q3 2017 · Jun 30, 2016 $63.96K
Operating Cash Flow Q3 2017 · Mar 31, 2016 −$167.92K
Cash And Equivalents Q3 2017 · Mar 31, 2016 $20.85K
Cash And Equivalents Q3 2017 · Jun 30, 2015 $13.77K
Sga Expense Q3 2017 · Mar 31, 2016 $46.69K
Sga Expense Q3 2017 · Mar 31, 2016 $154.45K
Net Income Q3 2017 · Mar 31, 2016 −$40.82K
Net Income Q3 2017 · Mar 31, 2016 −$138.37K
Gross Profit Q3 2017 · Mar 31, 2016 $5.87K
Gross Profit Q3 2017 · Mar 31, 2016 $16.08K
Cost Of Revenue Q3 2017 · Mar 31, 2016 $11.39K
Cost Of Revenue Q3 2017 · Mar 31, 2016 $33.36K
Revenue Q3 2017 · Mar 31, 2016 $17.26K
Revenue Q3 2017 · Mar 31, 2016 $49.45K